Total records found: 182
Disclaimer
Hide HeadlineShow Headline
Sort
Release Time Stock Code Stock Short Name Document
Release Time: 31/03/2023 18:12 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Terms of Reference of the Audit Committee]
TERMS OF REFERENCE OF THE AUDIT COMMITTEE (440KB)
Release Time: 31/03/2023 18:09 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Terms of Reference of the Nomination Committee]
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE (428KB)
Release Time: 31/03/2023 18:06 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Terms of Reference of the Remuneration Committee]
TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE (429KB)
Release Time: 30/03/2023 22:42 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Final Results / Amendment of Constitutional Documents / Capital Reorganisation]
(1) ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2022; (2) PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION; AND (3) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL (658KB)
Release Time: 28/03/2023 20:51 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT - COMPLETION OF ENROLLMENT OF SUBJECTS IN PHASE III CLINICAL TRIAL OF KX-826 FOR TREATMENT OF MALE AGA IN CHINA (431KB)
Release Time: 28/03/2023 20:44 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Inside Information]
CHANGE IN USE OF PROCEEDS AND THE RESULTS OF PHASE III CLINICAL TRIAL OF PRUXELUTAMIDE MONOTHERAPY FOR THE TREATMENT OF PROSTATE CANCER (458KB)
Release Time: 17/03/2023 06:08 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING (424KB)
Release Time: 01/03/2023 15:01 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023 (63KB)
Release Time: 10/02/2023 20:57 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT TOP-LINE RESULTS OF PHASE I CLINICAL TRIAL OF GT20029 IN THE U.S. (432KB)
Release Time: 01/02/2023 16:26 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023 (63KB)
Release Time: 03/01/2023 12:11 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022 (63KB)
Release Time: 16/12/2022 17:17 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Next Day Disclosure Returns - [Others]
Next Day Disclosure Return (88KB)
Release Time: 16/12/2022 17:07 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Placing / Issue of Shares under a General Mandate / Change in Shareholding]
COMPLETION OF TOP-UP PLACING OF EXISTING SHARES AND SUBSCRIPTION FOR SHARES UNDER GENERAL MANDATE (100KB)
Release Time: 11/12/2022 18:05 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Placing / Issue of Shares under a General Mandate / Change in Shareholding]
(1) TOP-UP PLACING OF EXISTING SHARES (2) SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE AND (3) SALE OF SHARES BY THE VENDOR (192KB)
Release Time: 09/12/2022 22:22 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Inside Information / Placing / Issue of Shares under a General Mandate]
INSIDE INFORMATION PROPOSED TOP-UP PLACING AND SHARE PLACEMENT ARRANGEMENTS (92KB)
Release Time: 01/12/2022 18:08 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT PHASE II CLINICAL TRIAL OF KX-826 FOR TREATMENT OF FEMALE AGA IN CHINA MET PRIMARY ENDPOINT (102KB)
Release Time: 01/12/2022 12:46 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022 (59KB)
Release Time: 24/11/2022 08:04 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
TOP-LINE RESULTS OF PHASE I CLINICAL TRIAL OF GT20029 IN CHINA (155KB)
Release Time: 01/11/2022 16:37 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022 (59KB)
Release Time: 27/10/2022 16:31 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT COMPLETION OF SUBJECT ENROLLMENT AND DOSING IN PHASE I CLINICAL TRIAL OF GT20029 IN THE U.S. (140KB)
Release Time: 16/10/2022 18:29 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT COMPLETION OF PATIENT ENROLLMENT IN PHASE II CLINICAL TRIAL OF KX-826 FOR TREATMENT OF ACNE VULGARIS IN CHINA (89KB)
Release Time: 09/10/2022 18:26 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Miscellaneous]
GRANT OF RESTRICTED SHARES OR RESTRICTED SHARE UNITS (156KB)
Release Time: 07/10/2022 17:08 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022 (61KB)
Release Time: 06/10/2022 10:43 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022 (60KB)
Release Time: 28/09/2022 18:30 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Circulars - [Other]
Notification Letter to Non-registered holders - Notice of Publication of 2022 Interim Report and Request Form (1MB)
Release Time: 28/09/2022 17:35 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Financial Statements/ESG Information - [Interim/Half-Year Report]
INTERIM REPORT 2022 (2MB)
Release Time: 07/09/2022 18:27 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Next Day Disclosure Returns - [Others]
Next Day Disclosure Return (85KB)
Release Time: 07/09/2022 18:16 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Placing / Issue of Shares under a General Mandate / Change in Shareholding]
COMPLETION OF TOP-UP PLACING OF EXISTING SHARES AND SUBSCRIPTION FOR SHARES UNDER GENERAL MANDATE (94KB)
Release Time: 01/09/2022 12:42 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022 (59KB)
Release Time: 01/09/2022 08:59 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Resumption]
EXCHANGE NOTICE - RESUMPTION OF TRADING (2KB, HTM)
Release Time: 31/08/2022 16:31 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Placing / Issue of Shares under a General Mandate / Change in Shareholding / Resumption]
CLARIFICATION ANNOUNCEMENT AND RESUMPTION OF TRADING (258KB)
Release Time: 31/08/2022 12:08 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Trading Halt]
TRADING HALT (85KB)
Release Time: 31/08/2022 09:56 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Trading Halt]
EXCHANGE NOTICE - TRADING HALT (2KB, HTM)
Release Time: 31/08/2022 08:29 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Placing / Issue of Shares under a General Mandate / Change in Shareholding]
(1) TOP-UP PLACING OF EXISTING SHARES (2) SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE AND (3) SALE OF SHARES BY THE VENDOR (173KB)
Release Time: 30/08/2022 22:45 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Inside Information / Placing / Issue of Shares under a General Mandate]
INSIDE INFORMATION PROPOSED TOP-UP PLACING AND SHARE PLACEMENT ARRANGEMENTS (92KB)
Release Time: 29/08/2022 22:58 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Interim Results]
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2022 (293KB)
Release Time: 17/08/2022 06:04 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING (79KB)
Release Time: 09/08/2022 16:40 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT COMPLETION OF SUBJECT ENROLMENT AND DOSING IN PHASE I CLINICAL TRIAL OF GT20029 IN CHINA (92KB)
Release Time: 03/08/2022 18:50 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT COMPLETION OF PATIENT ENROLMENT IN PHASE II CLINICAL TRIAL OF KX-826 FOR TREATMENT OF MALE AGA PATIENTS IN THE US (89KB)
Release Time: 01/08/2022 17:21 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022 (60KB)
Release Time: 22/07/2022 20:19 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Connected Transaction]
SUPPLEMENTAL ANNOUNCEMENT CONNECTED TRANSACTION PROVISION OF LOAN (95KB)
Release Time: 04/07/2022 16:53 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022 (60KB)
Release Time: 30/06/2022 17:53 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Results of AGM]
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 30 JUNE 2022 (44KB)
Release Time: 29/06/2022 22:43 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Connected Transaction]
SUPPLEMENTAL ANNOUNCEMENT CONNECTED TRANSACTION PROVISION OF LOAN (93KB)
Release Time: 06/06/2022 13:08 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022 (61KB)
Release Time: 30/05/2022 17:51 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Proxy Forms
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING (94KB)
Release Time: 30/05/2022 17:49 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period]
NOTICE OF ANNUAL GENERAL MEETING (98KB)
Release Time: 30/05/2022 17:46 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Circulars - [Re-election or Appointment of Director subject to Shareholders' Approval / General Mandate / Explanatory...
More
Circulars - [Re-election or Appointment of Director subject to Shareholders' Approval / General Mandate / Explanatory Statement for Repurchase of Shares]
]
(1) RE-ELECTION OF RETIRING DIRECTORS; (2) RE-APPOINTMENT OF AUDITOR; (3) GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; AND (4) NOTICE OF ANNUAL GENERAL MEETING (264KB)
Release Time: 27/05/2022 06:07 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Financial Statements/ESG Information - [Environmental, Social and Governance Information/Report]
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2021 (2MB)
Release Time: 05/05/2022 22:32 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS (84KB)
Release Time: 05/05/2022 22:31 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities / Change of Audit...
More
Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities / Change of Audit Committee Member]
]
(1) CHANGE OF DIRECTORS; AND (2) CHANGE IN COMPOSITION OF AUDIT COMMITTEE (102KB)
Release Time: 05/05/2022 11:22 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022 (60KB)
Release Time: 04/05/2022 18:15 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT FIRST PATIENT DOSING IN THE UNITED STATES IN PHASE II CLINICAL TRIAL OF ALK-1 ANTIBODY AND NIVOLUMAB COMBINATION THERAPY FOR THE TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA (90KB)
Release Time: 27/04/2022 18:06 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Financial Statements/ESG Information - [Annual Report]
ANNUAL REPORT 2021 (2MB)
Release Time: 22/04/2022 12:03 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Connected Transaction]
SUPPLEMENTAL ANNOUNCEMENT CONNECTED TRANSACTION PROVISION OF LOAN (93KB)
Release Time: 06/04/2022 17:27 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022 (60KB)
Release Time: 06/04/2022 07:01 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION TOP-LINE RESULTS FROM PROXALUTAMIDE PHASE III CLINICAL TRIAL FOR TREATING OUTPATIENTS WITH MILD TO MODERATE COVID-19 (94KB)
Release Time: 25/03/2022 22:54 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Final Results]
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2021 (296KB)
Release Time: 11/03/2022 16:33 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING (85KB)
Release Time: 06/03/2022 19:54 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT COMPLETION OF PATIENT ENROLLMENT IN PHASE II CLINICAL TRIAL OF KX-826 IN CHINA FOR THE TREATMENT OF AGA IN FEMALE PATIENTS (90KB)
Release Time: 01/03/2022 18:14 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022 (59KB)
Release Time: 01/03/2022 17:45 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT ENROLLMENT AND DOSING OF FIRST PATIENTS IN PHASE II CLINICAL TRIAL OF KX-826 FOR AGA IN THE UNITED STATES (90KB)
Release Time: 18/02/2022 18:18 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Change in Company Secretary]
CHANGE OF JOINT COMPANY SECRETARY AND AUTHORIZED REPRESENTATIVE AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES (195KB)
Release Time: 11/02/2022 19:15 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT FIRST PATIENT DOSING IN CHINA IN PHASE III CLINICAL TRIAL OF PROXALUTAMIDE FOR THE TREATMENT OF COVID-19 OUTPATIENTS (51KB)
Release Time: 09/02/2022 06:18 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Connected Transaction]
CONNECTED TRANSACTION PROVISION OF LOAN (94KB)
Release Time: 07/02/2022 14:54 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022 (60KB)
Release Time: 03/02/2022 18:14 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT FIRST SUBJECT DOSING IN PHASE I CLINICAL TRIAL OF GT20029 (AR-PROTAC) IN THE UNITED STATES (90KB)
Release Time: 03/02/2022 18:11 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS (83KB)
Release Time: 03/02/2022 18:08 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities]
CHANGE OF DIRECTORS (95KB)
Release Time: 24/01/2022 20:32 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT DOSING OF FIRST PATIENT FOR ACNE VULGARIS PHASE II CLINICAL TRIAL OF KX-826 IN CHINA (89KB)
Release Time: 03/01/2022 16:41 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021 (60KB)
Release Time: 02/01/2022 19:31 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT ENROLLMENT OF FIRST PATIENT AND INITIATION OF PHASE III CLINICAL TRIAL OF KX-826 FOR TREATMENT OF AGA (42KB)
Release Time: 27/12/2021 19:12 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Inside Information]
ANNOUNCEMENT INSIDE INFORMATION INTERIM ANALYSIS FOR PHASE III STUDY OF PROXALUTAMIDE FOR PATIENTS WITH MILD TO MODERATE COVID-19 SYMPTOMS (43KB)
Release Time: 01/12/2021 17:06 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021 (59KB)
Release Time: 26/11/2021 19:23 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS (39KB)
Release Time: 26/11/2021 19:19 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Change in Company Secretary / Change in Directors or of Important Executive Functions or...
More
Announcements and Notices - [Change in Company Secretary / Change in Directors or of Important Executive Functions or Responsibilities]
]
CHANGE OF JOINT COMPANY SECRETARY AND RESIGNATION OF NON-EXECUTIVE DIRECTOR (50KB)
Release Time: 24/11/2021 22:42 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT PIVOTAL STUDY OF PYRILUTAMIDE FOR TREATMENT OF ANDROGENETIC ALOPECIA MALE PATIENTS RECEIVED CLEARANCE BY CHINA NMPA (42KB)
Release Time: 12/11/2021 12:06 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT DOSING OF FIRST FEMALE PATIENT IN PHASE II CLINICAL TRIAL OF KX-826 IN CHINA (42KB)
Release Time: 02/11/2021 17:42 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT FIRST PATIENT DOSING IN TRIAL OF ALK-1 IN COMBINATION WITH KN046 IN ADVANCED OR REFRACTORY SOLID TUMORS (59KB)
Release Time: 01/11/2021 17:06 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Miscellaneous]
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2020 (38KB)
Release Time: 01/11/2021 12:57 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2021 (59KB)
Release Time: 21/10/2021 21:54 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT CHINA NMPA APPROVES CLINICAL TRIAL OF PD-L1/TGF-B DUAL-TARGETING ANTIBODY (GT90008) FOR THE TREATMENT OF ADVANCED SOLID TUMOURS (74KB)
Release Time: 11/10/2021 12:10 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT CHINA NMPA APPROVES CLINICAL TRIAL OF ALK-1 AND NIVOLUMAB COMBINATION THERAPY FOR THE FIRST-LINE TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA (42KB)
Release Time: 05/10/2021 14:56 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2021 (59KB)
Release Time: 04/10/2021 12:27 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT FIRST PATIENT DOSING IN US PHASE III CLINICAL TRIAL OF PROXALUTAMIDE FOR THE TREATMENT OF HOSPITALIZED COVID-19 PATIENTS (42KB)
Release Time: 27/09/2021 20:41 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS (39KB)
Release Time: 27/09/2021 20:36 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities / Other - Miscellaneous]
GRANT OF RESTRICTED SHARE UNITS AND CHANGE OF NON-EXECUTIVE DIRECTOR (62KB)
Release Time: 27/09/2021 12:22 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Financial Statements/ESG Information - [Interim/Half-Year Report]
INTERIM REPORT 2021 (9MB)
Release Time: 26/09/2021 18:10 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL TRIAL OF PROXALUTAMIDE FOR THE TREATMENT OF HOSPITALIZED COVID-19 PATIENTS CONDITIONALLY APPROVED BY ANVISA IN BRAZIL (43KB)
Release Time: 08/09/2021 22:01 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT PHASE II CLINICAL TRIAL OF PYRILUTAMIDE ("KX-826")'S TREATMENT OF AGA IN CHINA REACHED PRIMARY ENDPOINT (43KB)
Release Time: 03/09/2021 16:39 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2021 (59KB)
Release Time: 01/09/2021 12:29 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT KINTOR PHARMA'S TWO PHASE III CLINICAL TRIALS OF PROXALUTAMIDE APPROVED BY NMPA FOR THE PROPOSED TREATMENT OF COVID-19 (39KB)
Release Time: 27/08/2021 22:55 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Interim Results]
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2021 (284KB)
Release Time: 25/08/2021 17:37 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT KINTOR PHARMA COLLABORATES WITH ETANA TO COMMERCIALISE PROXALUTAMIDE FOR THE TREATMENT OF COVID-19 IN INDONESIA (42KB)
Release Time: 20/08/2021 22:38 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT INCLUSION OF KINTOR AS A CONSTITUENT OF HANG SENG COMPOSITE INDEX (38KB)
Release Time: 10/08/2021 16:30 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING (81KB)
Release Time: 05/08/2021 16:41 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2021 (60KB)
Release Time: 28/07/2021 12:23 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT FIRST BATCH SUBJECTS DOSING IN PHASE I CLINICAL TRIAL OF GT20029 (AR-PROTAC) IN CHINA (42KB)
Release Time: 16/07/2021 12:00 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT KINTOR PHARMACEUTICAL RECEIVED FIRST EMERGENCY USE AUTHORISATION (EUA) FOR PROXALUTAMIDE FOR THE TREATMENT OF COVID-19 IN PARAGUAY (42KB)
Release Time: 15/07/2021 07:30 Stock Code: 09939 Stock Short Name: KINTOR PHARMA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT KINTOR PHARMACEUTICAL COLLABORATES WITH FOSUN PHARMA DEVELOPMENT TO COMMERCIALISE PROXALUTAMIDE FOR THE TREATMENT OF COVID-19 IN INDIA AND AFRICA (43KB)
Showing 100 of 182 records
Showing 100 of 182 records
Disclaimer

Information contained in the materials available under the web page containing the hyperlink to this disclaimer is posted on this website for the purpose of providing information to the public in Hong Kong. It is not intended as investment advice and must not be relied on as such. It is the sole responsibility of any person who is located outside of Hong Kong to check and comply with all applicable laws and regulations before accessing and using the materials and information.

Please note that the web page contains materials and information provided to HKEX electronically (including information provided in electronic format) by listed issuers, new listing applicants and relevant parties and there is no agency, employee or partner relationship between HKEX and such parties. HKEX does not assume responsibility for screening, editing or monitoring such materials and the information contained in the materials. The information contained in the materials is not verified by HKEX.

HKEX and/or its subsidiaries take no responsibility for the materials and information available under the web page, make no representation as to their accuracy, reliability, completeness or ownership and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the information. Some materials may contain hyperlinks to external websites or web pages for which HKEX and/or its subsidiaries are not responsible. (Please see HKEX's "Hyperlink Policy").

Nothing herein shall constitute or be considered to be a limitation upon or a waiver of the privileges and immunities of HKEX and its subsidiaries, which are specifically reserved.

Copyright exists in the information and materials available under the web page and may belong to HKEX, to the author or to any other party depending on the circumstances of publications. Reproduction, distribution, use and/or linking without consent from the relevant parties is not permitted.

If you believe or are aware that any information contained in the materials is inaccurate, erroneous, unlawful, obscene, defamatory or infringes any intellectual property rights of a third party, please contact HKEX e-Submission by email at: ESSHotline@hkex.com.hk.